Bespoke Extracts, Inc.: management transactions · United States · SEC (Form 4)

About Bespoke Extracts, Inc.

Bespoke Extracts, Inc. is a U.S.-listed microcap trading on the OTCQB under the ticker BSPK; based on the SEC filings reviewed, it is not currently listed on NYSE or NASDAQ. The company is incorporated in Nevada and maintains its corporate headquarters in Aurora, Colorado, United States. Its business profile has changed materially over time: while Bespoke originally had exposure to CBD-oriented products, its current strategy is centered on regulated cannabis markets in the United States, with a stronger emphasis on marijuana-derived consumer packaged goods and production services. The company traces its origins back to 1988, but the modern cannabis business was effectively launched in 2023 following the acquisition of a state-licensed adult-use marijuana infused products operation in Aurora, Colorado. Through its wholly owned subsidiary, Bespoke Extracts Colorado, LLC, the group operates a marijuana-infused products manufacturing facility. Since that acquisition, Bespoke has expanded into pre-roll production and related contract manufacturing, positioning itself around a focused portfolio of cannabis consumer brands and licensed supply relationships. Key products and brands include pre-rolled marijuana cigarettes, or pre-rolls, as well as branded consumer offerings such as Fresh Joints, Doobskis, DutchBlunts, and Wee Joints. The company states that it owns, manufactures, and distributes these products to licensed marijuana dispensaries across Colorado. That operating model suggests a hybrid strategy: part branded consumer goods, part manufacturing and production services for retail partners. For a company of this size, that mix can be attractive because it combines direct brand-building with recurring production volume from dispensary clients. From a competitive standpoint, Bespoke Extracts remains a small operator in a highly fragmented and intensely competitive cannabis industry. Its competitive advantages are likely to come from product quality, regulatory compliance, production reliability, and the ability to maintain relationships with licensed dispensaries. It is not a national multi-state operator; instead, it appears to be a Colorado-focused specialist with a narrower geographic footprint but potentially greater operational flexibility. That also means the company is exposed to sector-specific headwinds such as pricing pressure, compliance costs, and financing constraints that continue to affect cannabis businesses in the United States. Geographically, the business is concentrated in Colorado, where production and distribution are based. Recent 2025 company disclosures highlighted a strategic rebranding under “The Joint Company,” alongside modest revenue growth, improved gross profit, and lower operating expenses in the first quarter of 2025. Taken together, those updates indicate a management focus on efficiency, branding, and execution rather than rapid geographic expansion. For French-speaking investors, Bespoke Extracts is best viewed as a highly speculative U.S. cannabis microcap in the Health & Pharma sector, with a narrow operating base, a local market focus, and an evolving but clearly defined product and distribution strategy.